Imidafenacin is primarily used in the treatment of overactive bladder (OAB) syndrome. It works by blocking muscarinic receptors in the bladder, which helps to reduce involuntary bladder contractions. This leads to decreased urgency, frequency, and episodes of urinary incontinence, significantly improving the quality of life for patients suffering from OAB. The medication is typically administered orally and is known for its selective action on the bladder, minimizing side effects on other organs. Imidafenacin is often prescribed when other treatments have not been effective or are not suitable, providing a valuable option for managing OAB symptoms.